IMRIS Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMRSQ research report →
Price Chart
About the company
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment.
- CEO
- Marc Buntaine
- IPO
- 2023
- Employees
- 121
- HQ
- Minnetonka, MN, US
Get TickerSpark's AI analysis on IMRSQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $626
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.81
- Div Yield
- 0.00%
- Gross Margin
- 34.38%
- Op Margin
- -80.09%
- Net Margin
- -105.18%
- ROE
- -129.83%
- ROIC
- -63.89%
Latest fiscal year · YoY change
- Revenue
- $28.89M-37.3%
- Gross Profit
- $9.93M-36.6%
- Op Income
- $-23,140,000
- Net Income
- $-30,387,000+27.7%
- EPS
- $-0.58+30.1%
- OCF Growth
- +73.1%
- FCF Growth
- +72.9%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 7.79
- RSI (14)
- 48
- Avg Volume
- 20.77K
No earnings-call transcripts are available for IMRSQ yet.
- Free Float
- 64.6%
- Shares Outstanding
- 62.59M
- Float Shares
- 40.41M
Our IMRSQ coverage
Recent articles, reports, and earnings notes.
No research on IMRSQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IMRSQ report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.